Royalty Pharma plc RPRX
CIK 0001802768
Form 4 transactions dated Sep 1, 2023 to Sep 26, 2026, as reported to the SEC.
Insider purchases & sales
- Purchased
- $0.00
- Sold
- $129.60M
Sep 1, 2023 – Aug 19, 2026
Available records · partial months are marked ·
| Date | Insider | Activity | Trade value (USD) | % of prior holding | |
|---|---|---|---|---|---|
| 2025-12-26 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $786.38K 20,000 shares sold | 16.67% sold LLC holding | ▾ |
| 2025-12-19 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $767.58K 20,000 shares sold | 14.29% sold LLC holding | ▾ |
| 2025-12-18 | Lloyd George W. EVP, Investments & CLO | Sale10b5-1 footnote | $1.18M 30,654 shares sold | 100.00% sold LLC holding | ▾ |
| 2025-12-17 | Lloyd George W. EVP, Investments & CLO | Sale10b5-1 footnote | $3.06M 79,346 shares sold | 72.13% sold LLC holding | ▾ |
| 2025-12-16 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $766.42K 20,000 shares sold | 12.50% sold LLC holding | ▾ |
| 2025-12-15 | Coyne Terrance P. EVP & CFO | Sale10b5-1 footnote | $2.53M 65,832 shares sold | 11.11% sold LLC holding | ▾ |
| 2025-12-15 | Coyne Terrance P. EVP & CFO | Sale10b5-1 footnote | $143.85K 3,750 shares sold | 7.93% sold LLC holding | ▾ |
| 2025-12-05 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $913.59K 23,334 shares sold | 12.73% sold LLC holding | ▾ |
| 2025-12-05 | Urist Marshall EVP, Research & Investments | Sale10b5-1 footnote | $714.22K 18,242 shares sold | 71.15% sold Direct holding | ▾ |
| 2025-12-03 | Lloyd George W. EVP, Investments & CLO | Sale10b5-1 footnote | $4.38M 110,000 shares sold | 50.00% sold LLC holding | ▾ |
Showing 23 / 23 record groups in 2025. The complete set is available through the API.
Follow the people behind the trades.
Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.
- Download CSV
- Earlier filings
- Advanced screening & filtering
- API & AI access
＋ New accounts get free API credits to explore data beyond ownership filings.
For AI agents & developers
The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 23 of 23 purchase / sale groups and 30 of 51 other groups; the totals and the monthly series cover the whole window.
Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.
MCP https://api.akkrudata.ai/mcp
list_insider_transactions
{"ticker":"RPRX","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.
- MCP endpoint
- https://api.akkrudata.ai/mcp
- API / MCP documentation
- /documents
- llms.txt
- /llms.txt
Sources, coverage & how to read this data
Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.